Dear CEO/COO/CFO,
Over the past 11 years, SonoSite, Inc. has listened carefully to what hospital-based physicians and their administrative counterparts have been saying about reducing the costs in acute care.
As the world leader and specialist in point-of-care ultrasound, we share a responsibility to participate in ongoing efforts to ensure the delivery of higher-quality, more efficient, healthcare. With Medicare now restricting reimbursement for hospital-acquired infections and complications, controlling length of stay and unreimbursed days is more critical than ever. Unlike many of our competitors, we at SonoSite welcome the shift toward more responsible, episodic cost-assessment for the following reasons:
SonoSite’s bedside ultrasound has been clinically proven to reduce risks by increasing the accuracy of interventional procedures and is now recommended by two government-based agencies and three medical societies. As you undoubtedly know, there is a wide range of complications and corresponding costs that burden hospitals financially and otherwise.
We need not explain what these systemic enhancements might mean for your facility’s bottom line.
Please visit the clinical evidence page for additional details and to access the websites of the aforementioned government agencies and medical societies.
If you would like to interact more directly with SonoSite, please complete the CEO/COO/CFO Feedback form.
Sincerely,
Kevin M. Goodwin
President and CEO
- Healthcare Professions
- Anesthesiology
- Breast Surgery
- Cardiology
- Critical Care
- Emergency Medicine
- Endocrinology
- Internal Medicine
- Lipidology
- Longevity and Aging
- Nursing
- Obstetrics/Gynecology
- Orthopedic Surgery
- Physical Med/Rehab
- Primary Care
- Radiology
- Rheumatology
- Sports Medicine
- U.S. Government
- Vascular Surgery
- Veterinary
- CEO/CFO/COO
- CMO
- Hospital Administration
- Purchasing
E-mail sales or call 877-290-4911
